SHARE THIS
DALLAS—July 20, 2021 — CorroHealth has acquired Medical Savant after a successful year-long pilot of fully autonomous coding and charge capture. Automation exceeding 95% of encounters proved the benefits of combining Medical Savant Autonomous Coding with the CorroHealth Advanced Coding Solution (ACS).
DALLAS—October 8, 2020 — CorroHealth expands its Clinical Revenue Integrity solutions with the purchase of the analytics platform and review solutions from TCP Services and Analytics (“TCP”). A combination of artificial intelligence (“AI”) capabilities and physician-led quality reviews enhances the reimbursement cycle solutions from CorroHealth.
DALLAS—Sept. 30, 2020—Four healthcare services and technology organizations have launched under a combined brand —CorroHealth. CorroHealth, Visionary RCM, T-System and RevCycle+ joined forces to provide a greater breadth of reimbursement cycle, risk adjustment and quality solutions to health systems and payers. Global investment firm The Carlyle Group (NASDAQ: CG) owns a majority stake in CorroHealth, with Cannae Holdings, Inc. (NYSE: CNNE), Sanaka Group, and affiliates of TripleTree Holdings also serving as investors.
DALLAS—July 20, 2021 — CorroHealth has acquired Medical Savant after a successful year-long pilot of fully autonomous coding and charge capture. Automation exceeding 95% of encounters proved the benefits of combining Medical Savant Autonomous Coding with the CorroHealth Advanced Coding Solution (ACS).
DALLAS—October 8, 2020 — CorroHealth expands its Clinical Revenue Integrity solutions with the purchase of the analytics platform and review solutions from TCP Services and Analytics (“TCP”). A combination of artificial intelligence (“AI”) capabilities and physician-led quality reviews enhances the reimbursement cycle solutions from CorroHealth.
DALLAS—Sept. 30, 2020—Four healthcare services and technology organizations have launched under a combined brand —CorroHealth. CorroHealth, Visionary RCM, T-System and RevCycle+ joined forces to provide a greater breadth of reimbursement cycle, risk adjustment and quality solutions to health systems and payers. Global investment firm The Carlyle Group (NASDAQ: CG) owns a majority stake in CorroHealth, with Cannae Holdings, Inc. (NYSE: CNNE), Sanaka Group, and affiliates of TripleTree Holdings also serving as investors.
CorroHealth Makes Strategic Investment in SANTECHTURE, Infusing CorroHealth AI Capabilities into SANTECHTURE RCM Products Throughout GCC Region Dubai, UAE (June 5, 2025) – Global healthcare technology company CorroHealth has made a strategic investment into Dubai...
CorroHealth Named One of the 150 Top Places to Work in Healthcare in 2025 by Becker’s Healthcare PLANO, Texas (May 13, 2025) – Global healthcare technology company CorroHealth has been named to the prestigious list of the “150 Top Places to Work in Healthcare...
CorroHealth India Again Achieves Great Place To Work® Certification™ Second Time in Two Years Company Earns Place as One of India’s Top Healthcare Companies PLANO, Texas (February 24, 2025) – For the second time in two years, global healthcare technology...
